Featured Research

from universities, journals, and other organizations

Clozapine Effective For Controlling Dyskinesias In People With Severe Parkinson's

Date:
February 13, 2004
Source:
American Academy Of Neurology
Summary:
Low-dose clozapine is effective in treating dyskinesias (involuntary, often jerky movements) resulting from long-term levodopa therapy in patients with severe Parkinson's disease, according to a study in the February 10 issue of Neurology, the scientific journal of the American Academy of Neurology.

ST. PAUL, Minn. – Low-dose clozapine is effective in treating dyskinesias (involuntary, often jerky movements) resulting from long-term levodopa therapy in patients with severe Parkinson's disease, according to a study in the February 10 issue of Neurology, the scientific journal of the American Academy of Neurology.

Fifty patients participated in the 10-week, double-blind (where neither patients nor research staff know which participants are receiving the experimental treatment or a placebo) clinical trial performed at five hospitals in France. The patients performed self-evaluations of their motor performance fluctuations every two weeks, by means of a diary where they noted duration and intensity of dyskinesias.

Doses of clozapine (an antipsychotic drug used in managing schizophrenia) averaged 39.4 mg/day. Clozapine was taken once daily in the evening.

"Dyskinesias are normally very difficult to treat and pose a serious side effect of levodopa therapy, the most common treatment for Parkinson's patients," according to lead study author Franck Durif, MD, at the Hopital Gabriel Montpied in Clermont-Ferrand. "Our study supports previous preliminary findings that low dose clozapine can reduce dyskinesias by around 50 percent in some patients."

Levodopa-induced dyskinesias (LIDs) are thought to result from increased transmission of dopamine in the brain. Clozapine may be able to mitigate the transmission of toxically high levels of levodopa and thereby reduce its potency and lesson the severity and duration of LIDs, according to the study. "Overstimulation of D1 dopaminergic receptors is believed to be one of the most important mechanisms underlying LIDs in Parkinson's disease," according to Durif.

The study was supported by a grant from the French Ministry of Health.

###

The American Academy of Neurology, an association of more than 19,000 neurologists and neuroscience professionals, is dedicated to improving patient care through education and research. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as stroke, Alzheimer's disease, epilepsy, Parkinson's disease, autism and multiple sclerosis.

For more information about the American Academy of Neurology, visit its web site at http://www.aan.com.


Story Source:

The above story is based on materials provided by American Academy Of Neurology. Note: Materials may be edited for content and length.


Cite This Page:

American Academy Of Neurology. "Clozapine Effective For Controlling Dyskinesias In People With Severe Parkinson's." ScienceDaily. ScienceDaily, 13 February 2004. <www.sciencedaily.com/releases/2004/02/040212084412.htm>.
American Academy Of Neurology. (2004, February 13). Clozapine Effective For Controlling Dyskinesias In People With Severe Parkinson's. ScienceDaily. Retrieved August 29, 2014 from www.sciencedaily.com/releases/2004/02/040212084412.htm
American Academy Of Neurology. "Clozapine Effective For Controlling Dyskinesias In People With Severe Parkinson's." ScienceDaily. www.sciencedaily.com/releases/2004/02/040212084412.htm (accessed August 29, 2014).

Share This




More Health & Medicine News

Friday, August 29, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Killer Amoeba Found in Louisiana Water System

Killer Amoeba Found in Louisiana Water System

AP (Aug. 28, 2014) State health officials say testing has confirmed the presence of a killer amoeba in a water system serving three St. John the Baptist Parish towns. (Aug. 28) Video provided by AP
Powered by NewsLook.com
Who Could Be Burnt by WHO's E-Cigs Move?

Who Could Be Burnt by WHO's E-Cigs Move?

Reuters - Business Video Online (Aug. 28, 2014) The World Health Organisation has called for the regulation of electronic cigarettes as both tobacco and medical products. Ciara Lee looks at the impact of the move on the tobacco industry. Video provided by Reuters
Powered by NewsLook.com
CDC Director On Ebola Outbreak: 'It's Worse Than I Feared'

CDC Director On Ebola Outbreak: 'It's Worse Than I Feared'

Newsy (Aug. 28, 2014) CDC director Tom Frieden says the Ebola outbreak is even worse than he feared. But he also said there's still hope to contain it. Video provided by Newsy
Powered by NewsLook.com
Amid Grave Ebola Estimates, US to Test Vaccine

Amid Grave Ebola Estimates, US to Test Vaccine

AP (Aug. 28, 2014) The National Institutes of Health will start the first human safety trials of an experimental Ebola vaccine next week, amid a grave estimate from the World Health Organization that Ebola cases in West Africa could top 20,000. (Aug. 28) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins